I

t’s a holiday week. Things are slow. But we’re still keeping tabs on all things pharma and biotech. Here’s what we’re looking out for this week:

Bad news

If the goal is to bury bad news, this week is the time to do it. Whether it’s a bankruptcy, layoffs, or a decision to give up on an experimental drug, companies have plenty of incentive to get that press release out of the way while hardly anyone’s paying attention. (Don’t worry. We’ll be watching.)

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Recommended Stories

Sign up for our biotech newsletter, The Readout

A guide to what’s new in biotech — delivered straight to your inbox every weekday morning.